RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 67-77
  • Pointing to threat, pulling in profit

    Pointing to threat, pulling in profit
    WASHINGTON -- Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a...
  • Human Genome to lay off 97 workers

    Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...
  • State AG sues maker of diabetes drugs for false advertising

    State AG sues maker of diabetes drugs for false advertising
    Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market. The company also withheld data that showed the drugs...
  • Human Genome Sciences announces plan to lay off 114

    Rockville-based Human Genome Sciences has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline. Human Genome, which employs about 1,000 people in Rockville, could...
  • Tailored breast cancer drugs in focus at cancer meet

    Tailored breast cancer drugs in focus at cancer meet
    ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis. Roche's T-DM1 and Novartis's Afinitor...
  • Antidepressants and pregnancy

    Antidepressants and pregnancy
    Upon learning they are pregnant, most women dutifully nix the alcohol, sushi and caffeine. But what about antidepressants? Headlines about the potential risks of antidepressants on a developing fetus, including miscarriage, premature birth and newborn...
  • Women on the Pill have less menstrual pain

    Women on the Pill have less menstrual pain
    NEW YORK (Reuters Health) - Young women on birth control pills tend to have less painful menstrual periods than those not on the contraceptives, a new study finds. Swedish researchers found that of 2,100 women followed from age 19 to 24, those on the...
  • Group backs HPV shot recommendation for boys

    Group backs HPV shot recommendation for boys
    NEW YORK (Reuters Health) - Boys 11 years and up should get Merck & Co's Gardasil vaccine to protect them against HPV infections, which can cause genital warts as well as oral, penile and anal cancers, the nation's largest group of pediatricians said...
  • Asthma drugs may increase attacks in kids: report

    Asthma drugs may increase attacks in kids: report
    NEW YORK (Reuters Health) - One class of drugs used to prevent wheezing and shortness of breath in people with asthma may increase kids' risk of being hospitalized for an asthma attack, according to a new analysis from the U.S. Food and Drug...
  • UK switches to Merck's Gardasil for HPV vaccination

    UK switches to Merck's Gardasil for HPV vaccination
    LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil. The move underscores Gardasil's lead in a $1 billion-plus worldwide...
  • Consolidation wave poised to hit state's health care services, biopharma sectors

    Like a one-two punch, two major Maryland employers in the health care service and pharmaceutical industries were the targets last week of multibillion-dollar acquisition deals. Both homegrown companies — Human Genome Sciences Inc. and Catalyst...